Anthropic launched Claude Science as an AI workbench for scientific computing to facilitate research in biology and biomedicine. The company is supporting up to 50 projects with as much as $30,000 in credits each while offering selected biotechs as much as $50,000 in credits via a new rare disease initiative. To measure performance on biological datasets, the company developed the BioMysteryBench evaluation to test whether models can analyze real world data rather than textbook questions.

Chief Executive Officer Dario Amodei believes AI could cure most human disease in 5 to 10 years. Amodei said delivering undeniable results in science is required to build legitimacy and public trust, shifting the focus from marketing predictions to providing real world outcomes.

Sign in to suggest edits

Key sources

  1. SOURCE@wesroth“supporting up to 50 projects with as much as $30,000 in Claude credits each”x.com
  2. SUPPORT@wesroth“stop trying to market the future harder and deliver something undeniable”x.com
Markdown